Table 1

Demographic, anthropometric and biochemical characteristics of participants

Women, n=519 (436)*Men, n=346 (429)*Overall, n=865 (865)*
Mean age (SD) (years)47.3 (16.2)46.4 (13.3)46.8 (14.8)
Number by age group in years
 25–44*222 (214)136 (224)358 (439)
 45–64*225 (164)147 (150)372 (314)
 65+*72 (57)63 (55)135 (113)
Anthropometry
 Mean BMI (SD) (kg/m2)29.8 (8.2)26.4 (4.6)28.1 (6.7)
 Mean waist circumference (SD) (cm)92.6 (16.1)90.0 (12.0)91.3 (14.1)
 % BMI ≥25 kg/m273.9 (69.1 to 78.3)55.7 (48.3 to 62.8)64.9 (60.6 to 68.9)
 % BMI ≥30 kg/m242.5 (37.7 to 47.4)22.3 (17.4 to 28.1)32.5 (28.8 to 36.4)
 % IDF abdominal obesity80.1 (75.6 to 84.0)35.0 (27.9 to 42.8)57.7 (52.4 to 62.9)
 % AHA/NHLBI abdominal obesity58.6 (54.1 to 63.0)18.0 (13.6 to 23.3)38.4 (34.4 to 42.6)
Measures of glycemia
 Mean fasting plasma glucose (SD) (mmol/L)5.3 (1.4)5.2 (0.8)5.3 (1.1)
 Mean HbA1c (SD) (%)5.8 (0.8)5.7 (0.4)5.7 (0.6)
 Mean HbA1c (SD) (mmol/mol)40 (8.7)39 (4.4)39 (6.6)
Hyperglycemia (ADA categories)
 % fasting plasma glucose ≥5.6 mmol/L21.1 (16.8 to 26.2)22.6 (18.2 to 27.7)21.9 (18.8 to 25.3)
 % HbA1c ≥5.7% (39 mmol/mol)58.9 (54.6 to 63.0)49.4 (42.9 to 55.9)54.2 (50.1 to 58.1)
 % total hyperglycemia63.5 (59.2 to 67.7)54.3 (47.3 to 61.1)58.9 (54.7 to 63.0)
Hyperglycemia (WHO categories)
 % fasting plasma glucose ≥6.1 mmol/L9.8 (6.8 to 14.0)9.8 (7.0 to 13.6)9.8 (7.6 to 12.6)
 % HbA1c ≥ 6.0% (42 mmol/mol)27.6 (23.2 to 32.5)21.8 (17.6 to 26.5)24.7 (21.6 to 28.1)
 % total hyperglycemia29.7 (24.9 to 35.0)25.2 (20.4 to 30.6)27.5 (24.0 to 31.3)
  • *Number of participants: numbers in brackets are weighted values as described in the text. Prevalence is given as point estimates with 95% CIs.

  • ADA, American Diabetes Association; AHA, American Heart Association; BMI, body mass index; HbA1c, hemoglobin A1c; IDF, International Diabetes Federation; NHLBI, National Heart, Lung, and Blood Institute; WHO, World Health Organization.